<DOC>
	<DOC>NCT02052167</DOC>
	<brief_summary>This study is planned to evaluate the human factor (HF)/usability of pediatric or adolescent JIA patients and the caregivers of Juvenile Idiopathic Arthritis (JIA) patients with the Methotrexate Prefilled Pen (including a label comprehension assessment and a device robustness evaluation).</brief_summary>
	<brief_title>Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Juvenile</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Main patient of either gender aged â‰¥2 to &lt;21 years of age is a suitable candidate for treatment with injectable methotrexate for JIA per the patient's primary rheumatologist, with the previous or current diagnosis of active polyarticular course JIA Main Is a female patient who is pregnant, trying to become pregnant, or breastfeeding, or of childbearing potential, sexually active but not practicing a highly reliable method of birth control during the study and at least 6 months thereafter Has contraindications for methotrexate Has a history of or current inflammatory arthritis or rheumatic autoimmune disease other than JIA Is unable, or does not have a caregiver able to comprehend written labeling and training materials</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>